Unigestion Holding SA Sells 1,036 Shares of Varian Medical Systems, Inc. (NYSE:VAR)

Unigestion Holding SA lowered its position in Varian Medical Systems, Inc. (NYSE:VAR) by 25.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,041 shares of the medical equipment provider’s stock after selling 1,036 shares during the period. Unigestion Holding SA’s holdings in Varian Medical Systems were worth $362,000 as of its most recent SEC filing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Several other large investors have also recently made changes to their positions in VAR. Arrow Financial Corp bought a new position in shares of Varian Medical Systems in the 2nd quarter worth approximately $27,000. Quantamental Technologies LLC bought a new position in shares of Varian Medical Systems in the 2nd quarter worth approximately $29,000. Financial Gravity Wealth Inc. raised its position in shares of Varian Medical Systems by 1,646.2% in the 2nd quarter. Financial Gravity Wealth Inc. now owns 227 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 214 shares in the last quarter. Flagship Harbor Advisors LLC bought a new position in shares of Varian Medical Systems in the 2nd quarter worth approximately $32,000. Finally, FinTrust Capital Advisors LLC raised its position in shares of Varian Medical Systems by 651.6% in the 2nd quarter. FinTrust Capital Advisors LLC now owns 233 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. 91.48% of the stock is owned by hedge funds and other institutional investors.

In related news, SVP John W. Kuo sold 465 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $116.30, for a total transaction of $54,079.50. Following the completion of the transaction, the senior vice president now owns 35,411 shares of the company’s stock, valued at approximately $4,118,299.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In the last ninety days, insiders have sold 1,395 shares of company stock valued at $158,388. 0.78% of the stock is owned by corporate insiders.

VAR stock traded up $1.30 on Friday, reaching $124.76. 488,581 shares of the company traded hands, compared to its average volume of 665,692. Varian Medical Systems, Inc. has a one year low of $103.92 and a one year high of $142.50. The company has a market cap of $11.27 billion, a P/E ratio of 26.95, a price-to-earnings-growth ratio of 2.87 and a beta of 0.87. The firm has a fifty day simple moving average of $117.33 and a 200-day simple moving average of $123.18.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, October 23rd. The medical equipment provider reported $1.21 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.21. Varian Medical Systems had a return on equity of 24.42% and a net margin of 9.65%. The company had revenue of $878.90 million during the quarter, compared to analyst estimates of $858.47 million. During the same quarter last year, the company earned $1.16 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. As a group, sell-side analysts forecast that Varian Medical Systems, Inc. will post 5.39 earnings per share for the current fiscal year.

VAR has been the subject of several research reports. ValuEngine lowered Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, August 20th. Zacks Investment Research lowered Varian Medical Systems from a “strong-buy” rating to a “hold” rating and set a $139.00 target price for the company. in a research report on Saturday, July 27th. Robert W. Baird set a $158.00 target price on Varian Medical Systems and gave the stock a “buy” rating in a research report on Friday, July 26th. BTIG Research raised Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $130.00 target price for the company in a research report on Monday, October 14th. Finally, TheStreet lowered Varian Medical Systems from a “b” rating to a “c+” rating in a research report on Monday, August 5th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Varian Medical Systems currently has a consensus rating of “Buy” and an average target price of $145.11.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Recommended Story: Municipal Bonds

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Leave a Reply

Your email address will not be published. Required fields are marked *